Akero Therapeutics Inc. (AKRO)
NASDAQ: AKRO
· Real-Time Price · USD
49.42
-0.67 (-1.34%)
At close: Aug 15, 2025, 3:59 PM
48.69
-1.48%
After-hours: Aug 15, 2025, 07:10 PM EDT
Akero Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 4K | 4K | 4K | 284K | 284K | 284K | 284K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 3K | 4K | 5K | 5K | 9K | 77K | 144K | 207K | 268K | 264K | 260K | 258K | 252K | 247K | 244K | 181K | 121K | 61K |
Gross Profit | 1K | n/a | -1K | -5K | -9K | -77K | -144K | -207K | -268K | -264K | -260K | -258K | -252K | -247K | -244K | -181K | -121K | -61K |
Operating Income | -321.48M | -306.35M | -285.42M | -269.27M | -234.18M | -204.07M | -172.87M | -136.42M | -125.89M | -117.86M | -115.16M | -122.17M | -110.44M | -111.81M | -100.89M | -98.23M | -95.42M | -82.9M |
Interest Income | 42.3M | 41.74M | 38.03M | 36.41M | 34.01M | 28.43M | 24.21M | 16.63M | 8.78M | 3.62M | 266K | 266K | 266K | 22K | 38K | 38K | 173K | 420K |
Pretax Income | -283.96M | -269.44M | -252.06M | -237.22M | -204.18M | -179.27M | -151.76M | -119.63M | -115.52M | -111.83M | -112.03M | -121.4M | -110.19M | -111.72M | -100.78M | -98.06M | -95.14M | -82.41M |
Net Income | -283.96M | -269.44M | -252.06M | -237.22M | -204.18M | -179.27M | -149.29M | -114.59M | -109.93M | -106.25M | -108.89M | -120.83M | -110.16M | -111.69M | -100.78M | -98.06M | -95.14M | -82.41M |
Selling & General & Admin | 41.14M | 39.94M | 37.92M | 37.67M | 36.18M | 33.41M | 31.07M | 29.69M | 32.71M | 31.3M | 29.87M | 27.5M | 21.38M | 20.14M | 19.13M | 18.47M | 17.75M | 16.18M |
Research & Development | 280.35M | 266.41M | 247.5M | 231.6M | 198M | 170.66M | 141.8M | 106.73M | 93.18M | 86.56M | 85.28M | 94.67M | 89.06M | 91.67M | 81.76M | 79.76M | 77.67M | 66.73M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 244K | 244K | 259K | 282K | 71K | 109K | 166K | 278K | 245K |
Operating Expenses | 321.48M | 306.35M | 285.42M | 269.27M | 234.18M | 204.07M | 172.87M | 136.42M | 125.89M | 117.86M | 115.16M | 122.17M | 110.44M | 111.81M | 100.89M | 98.23M | 95.42M | 82.9M |
Interest Expense | 2.46M | 2.52M | 4.67M | 4.37M | 4.01M | 3.63M | 3.1M | 2.56M | 2M | 1.2M | 739K | 377K | 53K | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | -1K | -2K | -4K | -4K | -3K | -2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 321.49M | 306.36M | 285.43M | 269.27M | 234.18M | 204.07M | 172.87M | 136.42M | 125.89M | 117.86M | 115.16M | 122.17M | 110.44M | 111.81M | 100.89M | 98.23M | 95.42M | 82.9M |
Income Tax Expense | n/a | n/a | -42.28K | -42.28K | -42.28K | -42.28K | -2.46M | -5.04M | -5.59M | -5.59M | -3.15M | -582K | -84K | -134K | -162K | -162K | -117K | -67K |
Shares Outstanding (Basic) | 81.72M | 78.66M | 70.57M | 69.44M | 69.16M | 59.31M | 55.72M | 55.61M | 51.87M | 46.94M | 46.76M | 38.66M | 35.38M | 35.01M | 34.89M | 34.86M | 34.81M | 34.74M |
Shares Outstanding (Diluted) | 81.72M | 78.66M | 70.57M | 69.44M | 69.16M | 59.31M | 55.72M | 55.61M | 51.87M | 46.94M | 46.76M | 38.66M | 35.38M | 35.01M | 34.89M | 34.86M | 34.81M | 34.74M |
EPS (Basic) | -3.8 | -3.75 | -3.75 | -3.75 | -3.41 | -3.2 | -2.8 | -2.25 | -2.45 | -2.62 | -2.86 | -3.35 | -3.14 | -3.2 | -2.89 | -2.82 | -2.75 | -2.49 |
EPS (Diluted) | -3.8 | -3.75 | -3.75 | -3.75 | -3.41 | -3.2 | -2.8 | -2.25 | -2.45 | -2.62 | -2.86 | -3.35 | -3.14 | -3.2 | -2.89 | -2.82 | -2.75 | -2.49 |
EBITDA | -279.17M | -264.59M | -247.37M | -232.85M | -200.16M | -175.56M | -148.52M | -116.86M | -113.25M | -110.38M | -111.03M | -120.83M | -109.95M | -111.54M | -100.69M | -98.03M | -95.3M | -82.88M |
EBIT | -279.19M | -264.61M | -247.39M | -232.86M | -200.17M | -175.64M | -148.66M | -117.07M | -113.52M | -110.64M | -111.29M | -121.04M | -110.15M | -111.73M | -100.83M | -98.17M | -95.38M | -82.9M |
Depreciation & Amortization | 20.5K | 21.5K | 18K | 5K | 9K | 77K | 144K | 207K | 268K | 264K | 260K | 258K | 252K | 247K | 244K | 192K | 138K | 1.4M |